INOVIO Announces Pricing of $25 Million Public Offering
July 3, 2025
INOVIO Pharmaceuticals, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced the